cerrar
Tagged with Medicine

EU Acts on the Promise of Artificial Intelligence for Medicinal…
Pfizer’s David Isom and Monica Mihedji, writing in the November 2023 edition of the DIA’s Global Forum magazine, examine how the European…

Access to Medicine Index 2024 to Prioritise ‘Patient Reach’
New methodology for the 2024 Access to Medicine Index promises a stronger attempt to quantify whether drugs, vaccines, and diagnostics are actually…

A European Approach to Enable Equal Access to Precision Oncology
The European Coalition for Access to Comprehensive Genomic Profiling (ECGP) is a new initiative made up of industry association the European…

The African Medicines Agency and the Evolution of Continental…
Writing in the July 2023 edition of DIA’s Global Forum magazine, Nevena Miletic of Roche and the IFPMA’s Africa Regulatory Network and Ian Hudson…

4 Key Priorities for the European Medicines Agency in 2023
As part of a wide-ranging conversation with PharmaBoardroom published earlier this month, European Medicines Agency (EMA) Executive Director Emer…

Innovators Slam EU Pharma Overhaul while Generics Industry &…
As part of the EU’s Pharmaceutical Strategy for Europe, the European Commission has come out with a set of proposals to revise EU pharmaceutical…

Emer Cooke – Executive Director, European Medicines Agency…
In conversation at DIA Europe 2023 in Basel, European Medicines Agency Executive Director Emer Cooke looks back at the lessons EMA has taken from the…

Healthcare and Innovation Horizons in China
China has made major healthcare strides over the past decade with regulatory reforms, infrastructure improvements, and the advancement of universal…

EMA New Medicine Approvals 2022
The European Medicines Agency (EMA) recently published its annual Human Medicines Highlights report, documenting key figures on its recommendations…

Theodore Tryfon – VP, ELPEN Pharmaceutical; Co-CEO, ELPEN…
Speaking shortly after the unveiling of a EUR 55 million investment in a new factory in Keratea as part of a wider EUR 155 million spend up to 2025,…

Voluntary Licensing: Bridging The Gap Between Expanded Access…
During the COVID-19 pandemic discussions around increasing access to medicines for low and middle-income countries (LMICs) were often centred on…

Charles Gore – Executive Director, Medicines Patent Pool…
The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to, and facilitate the development…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here